1,366
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Pattern of use and awareness of side-effects of non-steroidal anti-inflammatory drugs in the Jordanian population

ORCID Icon, , , , , & show all
Article: 2242248 | Received 20 Mar 2023, Accepted 25 Jul 2023, Published online: 01 Aug 2023

References

  • Bacchi S, Palumbo P, Sponta A, et al. Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Antiinflamm Antiallergy Agents Med Chem. 2012;11(1):1–7. doi: 10.2174/187152312803476255.
  • Koffeman AR, Valkhoff VE, Celik S, et al. High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study. Br J Gen Pract. 2014;64(621):e191–e198. doi: 10.3399/bjgp14X677815.
  • Hughes CM, McElnay JC, Fleming GF. Benefits and risks of self-medication. Drug Saf. 2001;24(14):1027–1037. doi: 10.2165/00002018-200124140-00002.
  • Brooks P. Use and benefits of nonsteroidal anti-inflammatory drugs. Am J Med. 1998;104(3A):9S–13S. doi: 10.1016/s0002-9343(97)00204-0.
  • Cham E, Hall L, Ernst AA, et al. Awareness and use of over-the-counter pain medications: a survey of emergency department patients. South Med J. 2002;95(5):529–535. doi: 10.1097/00007611-200295050-00014.
  • Banerjee I, Bhadury T. Self-medication practice among undergraduate medical students in a tertiary care medical college, West Bengal. J Postgrad Med. 2012;58(2):127–131. doi: 10.4103/0022-3859.9717.
  • Conaghan PG. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int. 2012;32(6):1491–1502. doi: 10.1007/s00296-011-2263-6.
  • Davis A, Robson J. The dangers of NSAIDs: look both ways. Br J Gen Pract. 2016;66(645):172–173. doi: 10.3399/bjgp16X684433.
  • Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15–19. doi: 10.1136/bmj.329.7456.15.
  • Kifle ZD, Mekuria AB, Anteneh DA, et al. Self-medication practice and associated factors among private health sciences students in Gondar town, North West Ethiopia. A cross-sectional study. Inquiry. 2021;58:469580211005188. doi: 10.1177/00469580211005188.
  • Varpaei HA, Onsori P, Esmaeili F, et al. Self-medication practice, its causes and risk factors among people in Tehran, Iran: a descriptive-analytic study. J Commun Med. 2020;3(1):1025.
  • Amirimoghadam P, Zihayat B, Dabaghzadeh F, et al. Evaluation and awareness of over the counter use of non-steroidal anti-inflammatory drugs. J Appl Pharm Sci. 2017;7(3):154–159. doi: 10.7324/JAPS.2017.70325.
  • Duong M, Salvo F, Pariente A, et al. Usage patterns of ‘over the counter’ vs. prescription‐strength nonsteroidal anti‐inflammatory drugs in France. Br J Clin Pharmacol. 2014;77(5):887–895. doi: 10.1111/bcp.12239.
  • Sarganas G, Buttery AK, Zhuang W, et al. Prevalence, trends, patterns and associations of analgesic use in Germany. BMC Pharmacol Toxicol. 2015;16(1):28. doi: 10.1186/s40360-015-0028-7.
  • Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J. 2014;44(4):1055–1068. doi: 10.1183/09031936.00059814.
  • Pulvers K, Hood A, Limas EF, et al. Female smokers show lower pain tolerance in a physical distress task. Addict Behav. 2012;37(10):1167–1170. doi: 10.1016/j.addbeh.2012.05.002.
  • Ditre JW, Brandon TH, Zale EL, et al. Pain, nicotine, and smoking: research findings and mechanistic considerations. Psychol Bull. 2011;137(6):1065–1093. doi: 10.1037/a0025544.
  • Lei X, Jiang H, Liu C, et al. Self-medication practice and associated factors among residents in Wuhan, China. Int J Environ Res Public Health. 2018;15(1):68. doi: 10.3390/ijerph15010068.
  • Abd ElHafeez S, Hegazy R, Naga Y, et al. Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study. J Egypt Public Health Assoc. 2019;94(1):8. doi: 10.1186/s42506-018-0005-2.
  • Polónia J. Interaction of antihypertensive drugs with anti-inflammatory drugs. Cardiology. 1997;88(Suppl. 3):47–51. doi: 10.1159/000177507.
  • Floor-Schreudering A, De Smet PAGM, Buurma H, et al. NSAID-antihypertensive drug interactions: which outpatients are at risk for a rise in systolic blood pressure? Eur J Prev Cardiol. 2015;22(1):91–99. doi: 10.1177/2047487313505243.
  • Brook RD, Kramer MB, Blaxall BC, et al. Nonsteroidal anti-inflammatory drugs and hypertension. J Clin Hypertens. 2000;2(5):319–323.
  • Porteous T, Bond C, Hannaford P, et al. How and why are non-prescription analgesics used in Scotland? Fam Pract. 2005;22(1):78–85. doi: 10.1093/fampra/cmh719.
  • Roshi D, Toçi E, Burazeri G, et al. Users’ knowledge about adverse effects of non-steroidal anti-inflammatory drugs in Tirana, Albania. Mater Sociomed. 2017;29(2):138–142. doi: 10.5455/msm.2017.29.138-142.
  • Indermitte J, Reber D, Beutler M, et al. Prevalence and patient awareness of selected potential drug interactions with self-medication. J Clin Pharm Ther. 2007;32(2):149–159. doi: 10.1111/j.1365-2710.2007.00809.x.
  • Popa M. An examination of awareness of over-the-counter nonsteroidal anti-inflammatory drugs and adverse events [PhD thesis]. Minneapolis (MN): Walden University; 2011.
  • Albsoul-Younes AM, Jabateh SK, Abdel-Hafiz SM, et al. Awareness and frequency of potential side effects on nonsteroidal anti-inflammatory drugs among the Jordanian patient population. Saudi Med J. 2004;25(7):907–911.
  • Mullan J, Weston KM, Bonney A, et al. Consumer knowledge about over the counter NSAIDs: they don’t know what they don’t know. Aust N Z J Public Health. 2017;41(2):210–214. doi: 10.1111/1753-6405.12589.
  • Fine M. Quantifying the impact of NSAID-associated adverse events. Am J Manag Care. 2013;19(14 Suppl):s267–s272.